The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
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INTRODUCTION
The hematopoietic serine proteases constitute a superfamily of enzymes stored in cytoplasmic granules of hematopoietic cells, showing capacity for regulated secretion. Cathepsin G is one of four serine protease family members stored in the azurophil granules of neutrophil granulocytes; the neutrophil serine protease family also includes leukocyte elastase, proteinase 3 and the enzymatically inactive protease homologue azurocidin (Gullberg et al., 1997) .
Cathepsin G has been proposed to play several roles in inflammation and host defence.
Purified cathepsin G is cytotoxic against, or inhibits the growth of a number of microbes (Shafer and Onunka, 1989) (Shafer et. al., 1991) (Guyonnet et. al., 1991) . Elimination of cathepsin G in transgenic mice results in no obvious defects in microbial clearance, but combined deletion of the cathepsin G and leukocyte elastase genes leads to increased susceptibility to bacterial challenges (Tkalcevic et al., 2000) . Besides localization in azurophil granules, cathepsin G is present on the cell surface of neutrophils after degranulation, possibly enhancing chemotactic signaling (Maison et. al., 1991) (Tkalcevic et. al., 2000) (Lomas et al., 1995) . Cleavage of several blood clotting factors (e.g. coagulation factor V) and the thrombin receptor, leading to functional activation, are examples of potential extracellular roles of cathepsin G (Allen and Tracy, 1995; Turkington et al., 1986) . Uncontrolled proteolytic action of cathepsin G may contribute to tissue destruction seen in various chronic inflammatory disorders, such as allergic rhinitis (Westin et. al., 1999) . It has also been proposed that cathepsin G plays a role in tissue remodeling at sites of wounding or tissue injury, by cleavage and inactivation of chemoattractants for neutrophils, such as TNF-α (Scuderi et al., 1991) , IL-1 (Hazuda et al., 1990) and IL-8 (Padrines et al., 1994) . Consistently, cathepsin G deficient mice have an increased amount of neutrophils at inflammatory sites, which may be due to a high concentration of chemoattractants in the wound fluid (Abbott et al., 1998) . Lennartsson et al. "cathepsin G promoter" 
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Neutrophil serine proteases are mainly synthesized during the promyelocytic stage of myeloid differentiation, and after processing into mature enzymes the proteases are stored in azurophil granules as proteolytically active enzymes (Gullberg et. al. 1999) (Cowland and Borregaard, 1999) . No sorting motifs for sorting to granules have yet been identified (Gullberg, et. al. 1999) . Rather, it has been proposed that differentiation-related transcriptional control of the expression of the cathepsin G gene and other granule components, results in sorting into distinct granule subtypes (Arnljots et al., 1998) . Identification of important transactivating factors for the promyelocyte specific expression of elastase and proteinase 3 have been reported (Lutz et al., 2001; Nuchprayoon et al., 1997; Oelgeschlager et al., 1996; Sturrock et al., 1996; Sturrock et al., 2004) . These factors include the trancriptional activators PU.1, cmyb, C/EBP and a 40 kDa protein binding to a GC-rich cis-element. In contrast to the elastase and proteinase 3 genes, located on chromosome 19, the cathepsin G gene is located on chromosome 14 in a cluster with the genes encoding the cytotoxic T-cell protease granzyme B and granzyme H (Hanson et al., 1990; Yousef et al 2003) . Moreover, cathepsin G seems be expressed somewhat later than elastase and proteinase 3 (Garwicz et. al, 2005) .
The tissue-and maturation-specific expression of cathepsin G has been linked to a region stretching from 2.5 kb upstream to 0.8 kbp downstream of the first and last exon, respectively, as judged by its capacity to dictate expression in promyelocytes of transgenic mice (Grisolano et al., 1994) . Detailed molecular analysis of the promoter of cathepsin G including transactivating factors is, however, not available. Given the distinct chromosomal localization of cathepsin G, as compared to the proteinase 3 and leukocyte elastase genes, we asked whether the proximal promoter shows a similar functional and structural organization. Our results show that within 360 bp upstream of the translation start a proximal promoter is contained, including binding sites for PU.1, c-myb, C/EBP, and a GC-rich element, similar to the promoters of proteinase 3 and leukocyte elastase. Moreover, the C/EBP binding site, c- Lennartsson et al. "cathepsin G promoter" 6 myb binding sites and the GC-rich element show pronounced functional synergy, conferring strong expression from the promoter in myeloid cells.
MATERIALS AND METHODS

Cell culture
Monoblastic U937, promyelocytic NB4 and erythroid K562 were maintained in RPMI-1640 medium (GIBCO) supplemented with 10 % fetal calf serum (FCS, GIBCO). Exponentially growing cells were used for all experiments.
Genomic cloning
Cloning of human genomic DNA upstream of the transcription start of the cathepsin G gene was performed by PCR, utilizing the human Genomewalker TM -kit (Clontech), according to the manufacturer's recommendations. From published cDNA sequence (Hohn et al., 1989) oligonucleotide downstream primers specific for cathepsin G were synthesized for use in 
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CAAT-box at position -57 and -97, respectively, are present in the putative promoter region (numeration from the translation start site) (Hohn et al., 1989) .
Deletion and mutation constructs
To create sequential deletions of the promoter region, the nested primer described above was used as downstream primer, together with upstream primers complementary to sequences in the promoter at 807 bp, 564 bp, 360 bp, 300 bp, 250 bp, 200 bp and 150 bp, respectively. The upstream primers included a restriction site for Mlu I. For site directed mutagenesis of potential transcription factor binding sites, oligonucleotide primers including the desired mutations were synthesized and used in a two-step spliced overhang extension (SOE) PCR as described (Gullberg et al., 1992) . In the potential binding site for C/EBP, 5'-ATTCT-3' was changed to 5'-CGGTG-3'; in the PU.1 site, 5'-AGGAG-3' was changed to 5'-TCTTC-3'; in the putative binding site for c-myb, 5'-AGTTT-3' was changed to 5'-CACCG-3'; and in the GC-rich region, 5'-CCCAC-3' was mutated to 5'-AAACA-3'. All PCR's were performed with Pfu-polymerase. After subcloning into pGL3/basic, individual clones were sequenced to verify the creation of the desired mutations. In some constructs 6 or 10 bases were inserted between indicated transcription factor binding sites.
Transient transfection
15 µg of either pGL3/basic vector (negative control), pGL3/control vector (positive control) or pGL3/cathepsin G promoter construct, was mixed with 0.5µg pRL/SV40 vector (Promega) and added to U937 or K562 cells in 0.5 ml medium (18x10 6 cells/ml). Expression from pRL/SV40 was used as internal control for transfection efficiency. Transfection was performed using electroporation in a Genepulser II (Biorad) in a 0.4 cm cuvette, with the Lennartsson et al. "cathepsin G promoter" 8 electrical settings 280V/960µF at room temperature. Following electroporation, cells were seeded at 0.9x10 6 cells/ml medium and incubated for 16 hours at 37°C and after that subjected to dual luciferase assay. With NB4 cells, 30 µg of the plasmid was used for transfection of 9x10 6 cells/ml at 340 V/960µF, and luciferase activity was determined after 10 hours.
Dual luciferase assay
Cell lysis and dual luciferase assay were performed using the Dual Luciferase® reporter assay 
Western blotting
Western blot analysis of PU.1 was performed as previously described (Chylicki et al., 2000) .
Briefly, 5x10 6 U937 or NB4 cells were harvested, washed and lysed. After electrophoresis, proteins were electrophoretically transferred to a Hybond-P membrane (Amersham Pharmacia Biotech). A rabbit antiserum against PU.1 (sc-352, Santa Cruz) was used as primary antibody (diluted 1:1000) and peroxidase conjugated swine anti-rabbitserum as secondary antibody (P217, DAKO). As equal loading control was antibody against actin (sc-8432, Santa Cruz, diluted 1:5000) was used and peroxidase conjugated goat anti-mouseserum (170-6516, Lennartsson et al. "cathepsin G promoter" 9 Biorad) as secondary antibody. For detection, ECL Plus™ Western blotting detection system (Amersham Pharmacia Biotech) was used.
Chromatin immunoprecipitation (ChIP)
Chromatin immunoprecipitation (ChIP) was performed using the ChIP assay kit (Upstate Biotechnology), according to the manufacturer's instruction. Briefly, 1 x10 6 cells were crosslinked with 1% formaldehyde for 20 min, harvested and sonicated 4 × 40 seconds at 100% power using a UP 50H sonicator (Dr. Hielscher GmbH, Germany). ProteinA-sepharose and 6
µg of antibody were added and incubated overnight at 4°C; antibodies (Santa Cruz), were
and cyclin D1 (sc-753). As a negative control was ProteinA-sepharose added, without antibody. After washing and elution procedures according to the manufacturer's instruction, the immunocomplexes were resuspended in 40 µl distilled water. In the PCR (33 cycles) 4-10 µl of immunoprecipitated DNA was used as template and primers were as follows: C/EBPsite, forward primer 5'-GGAGTAGAAAACAGGAAGTGGGC-3' and reverse 5'-AGATGTGGGTGAGACCAGTGTAATC-3'; PU.1/c-myb/GC-rich-site, forward primer 5'-TTGATGGGTTGAGGGTTCTGG-3' and reverse 5'-CAGTCAGTTGCTGCTGTGCTTC-3'. To verify the ChIP specificity, a control PCR was performed with primers annealing 1-1.5 kbp downstream the translation start, forward primer 5'-CCTGGTGCGAGAAGACTTTGTG-3' and reverse 5'-TCCTTTCCTCCTCATTTACACTGG-3'. Lennartsson et al. "cathepsin G promoter" 10 3. RESULTS
Transcriptional activity studies
The transcription start of the cathepsin G gene has been determined previously to position -28
(numeration from the translation start site) (Salvesen et al., 1987) . To localize cis-acting regions in the promoter responsible for driving expression of cathepsin G, we performed transient transfections of pGL3/1.2 and pGL3/2.6 into monoblastic U937 cells or promyelocytic NB4 cells, followed by analysis of luciferase expression as described in 
Analysis of the proximal promoter by site directed mutagenesis
By matching the 360 bp promoter sequence to the transcription factor database TRANSFAC (http://motif.genome.jp/) potential cis-elements were identified (Figure 2 ). Given their involvement in the regulation of other genes expressed at the promyelocyte stage, we chose to study in detail the importance of potential sites for C/EBP, c-myb and PU.1. Thus, the binding sites for C/EBP, c-myb or PU.1 at -335 bp, -175 bp and -46 bp respectively, were mutated in pGL3/360 as described in "Materials and Methods". The modified constructs were transfected to U937 and NB4 cells, followed by measurements of the luciferase activity. Moreover, the GC-rich element at -86 bp was mutated, since a similar sequence is important for expression of proteinase 3 and leukocyte elastase genes (Sturrock et al., 1996) (Sturrock et al., 2004) .
Mutation of the C/EBP or c-myb binding sites resulted in a strong inhibition of the transcriptional activity in U937 cells, five-and eleven-fold respectively. Moreover, a fourteen-fold reduction was caused by mutation of the GC-rich element (Figure 3a) . Mutation of the PU.1 site affected expression more moderately, resulting in approximately 50% reduction ( Figure 3a) . In NB4 cells, similar effects were observed although the relative reduction after mutation of the C/EBP, c-myb site or the GC-rich element was only two-fold, compared to the dramatic decrease in U-937 cells. Furthermore, mutation of the PU.1 site did not affect the transcriptional activity in NB4 cells (Figure 3b ). We conclude that the C/EBP and c-myb sites, as well as the GC-rich element, are critical for the transcriptional activity of cathepsin G proximal promoter. Moreover, the potential PU.1 site contributes to promoter activity in monocytic U937 cells, but not in myeloid NB4 cells, suggesting higher PU.1-activity in U937 cells. Western blotting of PU.1 indeed showed a higher level of PU.1 in U937 cells (Figure 4 ), consistent with a role of PU.1 as an important transcription factor for high expression of cathepsin G.
Binding of C/EBP, c-myb and PU.1 to cathepsin G promoter in vivo
Our results indicate direct binding of C/EBP, c-myb and PU.1 to the promoter of cathepsin G.
In addition, Sp1 is a candidate for binding to the GC-rich site (Imataka et al., 1992) . To demonstrate direct binding in vivo, we performed chromatin immuno-precipitation (ChIP) as described in "Materials and Methods". After crosslinking of proteins to DNA in U937 cells, the DNA was sonicated. Immunoprecipitations with antibodies to C/EBPα, C/EBPε, Sp1, PU.1 or c-myb were performed, followed by PCR-amplification of the promoter-region with specific primers. As negative controls, immunoprecipitation with anti-cyclin D1 or addition of only Protein-A sepharose were performed. As shown in Figure 5a and 5b, 
Characterization of co-operative activation of the cathepsin G promoter
The dramatic effect on transcriptional activity by mutation of the c-myb-site, C/EBP-site or the GC-rich element (Figure 3a) , suggested that these cis-elements with corresponding transcription factors functionally interact with each other. Therefore, minor changes in the architecture of the promoter should disrupt or reduce transcriptional activity. To investigate this issue, we introduced small insertions between the C/EBP and the c-myb site, or between the c-myb site and the GC-rich element. Six bp or ten bp insertions were introduced to create half-or full helical turns of the DNA-helix, respectively (Idres et al., 2001 ). The reporter constructs were transfected to U937 cells, since the previously described mutations of the binding sites had the most pronounced effect in this cell line (Figure 3) . A 6 bp insertion between the C/EBP and c-myb sites slightly inhibited the promoter activity, while a 10 bp insertion fully restored the activity (Figure 6 ). Although observed differences in activity did not reach statistical significance, the results are consistent with the notion that an interaction between transcription factors binding to the C/EBP and c-myb sites are important for promoter activity and that correct three-dimensional positioning of the turn of the DNA-helix is necessary for full functional interaction. A 6 bp insertion between the c-myb and GC-rich element did not significantly reduce transcriptional activity, while a 10 bp insertion clearly reduced promoter activity almost two-fold (Figure 6 ), further suggesting that an interaction between transcriptions factors is dependent on correct distance to each other. Lennartsson et al. "cathepsin G promoter" 
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DISCUSSION
The core promoter of a gene is positioned immediately adjacent to and upstream of the transcription start. The transcription start of the cathepsin G gene is located 28 bp upstream of the translation start (Salvesen et al 1987) . The core promoter binds RNA polymerase II and its accessory factors and directs the transcription to the start site. Several myeloid genes, including those encoding CD18 and CD11b receptor, do not contain a TATA-box (Rosmarin et al., 1992 ) (Pahl et al., 1991) . The azurophil granule proteins bactericidal/permeability increasing protein (BPI) (Lennartsson et al., 2003) , proteinase 3 (Sturrock et al., 1996) and cathepsin G (Hohn et al., 1989) , differ in that respect, since they do contain a TATA-box.
However, the functionality of the TATA-boxes in these genes remains to be demonstrated.
The regulatory promoter of a gene conferring tissue specific expression is typically within the first 500 bp upstream of the transcription start. In the present investigation, functional regulatory elements of the promoter of cathepsin G have been defined.
By screening the 5' flanking region of the cathepsin G gene (2.6 kbp upstream of the transcription start) for regulatory cis-elements, we found that the initial 360 bp were sufficient for maximal tissue specific expression. This conclusion is based on the findings of maximal promoter activity in U937 and NB4 cells, both with strong expression of endogenous cathepsin G, while the promoter was completely inactive in K562 cells, showing no expression of cathepsin G. Further deletion studies revealed important cis-elements in the regions 360-300 bp and 200-150 bp. In the identified region potential C/EBP and a c-myb binding sites are located at positions -335 bp and -175 bp, respectively. Our finding that mutations of these sites strongly decreased the transcriptional activity of the promoter confirms their importance. Five basepairs in each cis-element were mutated to give a strong modulation of the site without interfering with adjacent elements. C/EBP and c-myb regulate also other myeloid proteins, including the serine proteases proteinase 3 and leukocyte elastase Lennartsson et al. "cathepsin G promoter" 15 (Nuchprayoon et al., 1997; Tsutsumi-Ishii et al., 2000) (Oelgeschlager et al., 1996; Sturrock et al., 1996) , which makes them likely to be involved also in the regulation of cathepsin G.
Indeed, direct binding of C/EBPα, C/EBPε and c-myb, as shown by ChIP-analysis, confirms their role as transactivators of cathepsin G gene expression. In addition to the identified elements, distant cis-elements important for full physiological promoter activation may be located further up-or downstream of the identified promoter. Gene expression of both proteinase 3 and leukocyte elastase have been shown to be regulated by a distant enhancer element, binding Sp1 (Nuchprayoon et. al. 1999) . Similar distant activating cis-elements can not be excluded for cathepsin G.
The transcription factor binding to the GC-rich element was not precipitated with antibody against Sp1 and the identity of this trans-acting factor is therefore not clarified. Both proteinase 3 and leukocyte elastase promoters contain a similar GC-rich element, to which an unknown 40kDa protein is bound (Sturrock et al., 1996) (Sturrock et al., 2004) . It is therefore likely that a common 40kDa protein binds to the GC-rich element in the proteinase 3, elastase and cathepsin G promoter. Moreover, all three serine protease gene promoters contain a functional PU.1 binding site just downstream to the GC-rich element, indicating a similar promoter organisation.
The dramatic reduction of promoter activity after mutation of either the c-myb, C/EBP or GCrich element suggests that these cis-elements and corresponding transcription factors cooperatively regulate promoter activity. This notion is supported by the decrease of transcriptional activity as a result of small insertions in the DNA sequence between the ciselements. In order not to disturb the binding of transcription factors, the insertions were made at a 19-124 bp distance from the cis-elements. Evidence for a direct protein interaction between transcription factors remains, however, to be demonstrated.
PU.1 is a myeloid master regulator involved in the regulation of many myeloid specific genes, and PU.1 is together with C/EBPα essential for differentiation into the granulocytic lineage (Sturrock et al., 2004 ) (Borregaard et al., 2001) . Paradoxically, C/EBPα can antagonize PU.1 in the lineage choice into neutrophilic differentiation, whereas PU.1 activity is more important for monocytic differentiation (Reddy et. al., 2002) . However, it has been shown that antagonistic relationships can become co-operative under certain circumstances, such as for PU.1 and GATA-2 (Walsh et. al., 2002) . Our results indicate that C/EBP and PU.1 cooperate in transcriptional activation of cathepsin G, as judged by the twofold reduction of transcriptional activity in monoblastic U937 cells after mutation of the PU.1 site. In promyelocytic NB4 cells, on the other hand, no effect on transcriptional activity of the PU.1 binding site mutation was seen, indicating that PU.1 activity is higher in U937 cells. This notion is supported by the finding of higher levels of PU.1 protein in U937 cells, as compared to NB4 cells. However, the protein level and transcriptional activity do not necessarily correlate, since PU.1 activity is also regulated post-transcriptionally (Marden et. al., 2003) .
In conclusion, in spite of distinct chromosomal localization, the proximal promoter of the cathepsin G gene shows a similar functional and structural organization as those of the proteinase 3 and leukocyte elastase genes. We demonstrate that the promoter of cathepsin G is co-operatively activated by C/EBPα, C/EBPε, c-myb and a transcription factor binding to a GC-rich element. In addition, PU.1-binding is important for strong transcription of cathepsin G, particularly in monocytic cells. and immunoblot analysis using a polyclonal antiserum against PU.1. Immunoblotting with antibody against actin was used as equal loading control. Lennartsson et al. "cathepsin G promoter" 24 . Statistical significant differences (P-value <0.05) from pGL3/360 luciferase activity are labeled with an asterisk (*). Lennartsson et al. "cathepsin G promoter" 25 Figure 1a .
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